Zacks Investment Research on MSN
Veeva Systems (VEEV) stock slides as market rises: Facts to know before you trade
In the latest trading session, Veeva Systems (VEEV) closed at $158.27, marking a -4.06% move from the previous day. The stock's change was less than the S&P 500's daily gain of 0.17%. Elsewhere, the ...
Investors may be wondering whether Veeva Systems, at around US$160 per share, now offers good value or still looks expensive compared to its fundamentals and peers. The stock is up 0.8% over the past ...
Is VEEV a good stock to buy? We came across a bullish thesis on Veeva Systems Inc. on Danny’s Substack by Danny Green. In this article, we will summarize the bulls’ thesis on VEEV. Veeva Systems ...
Since its 2013 IPO, Veeva Systems' (NYSE: VEEV) returns have been strong -- the company has posted a compound annual growth rate (CAGR) of 13.6% through this period. However, the stock now faces ...
View Veeva Systems Inc Class A VEEV stock quote prices, financial information, real-time forecasts, and company news from CNN.
Zacks Investment Research on MSN
Here's why Veeva Systems (VEEV) is a strong growth stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...
Veeva Systems (VEEV) closed at $233.21 in the latest trading session, marking a -2.88% move from the prior day. This change lagged the S&P 500's 0.16% gain on the day. On the other hand, the Dow ...
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...
Image source: Getty Images. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical ...
Veeva Systems benefits from switching costs, since its clients depend on its services for critical everyday activities. The stakes are especially high for biotech and pharmaceutical companies that use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results